CIP
DPLO

Convergence Investment Partners’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Convergence Investment Partners’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-550
Closed -$11K – 1019
2018
Q1 		$11K Sell
550
-88,024
-99% -$2.05M ﹤0.01% 691
2017
Q4 		$1.78M Buy
+88,574
New +$1.74M 0.24% 148

Other funds holding DPLO

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Convergence Investment Partners's DPLO Position: Q2 2018 in Review

Convergence Investment Partners sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2018, closing a stake of 550 shares — an estimated $11K sold.

Convergence Investment Partners first reported a position in DPLO in Q4 2017 and held it in 2 quarters. The position peaked at $1.78M in Q4 2017. 206 funds tracked by Wall St. Rank hold DPLO as of Q2 2018.

  • Convergence Investment Partners reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2018 after selling out during the quarter.
  • Convergence Investment Partners sold 550 DIPLOMAT PHARMACY, INC. shares in Q2 2018, an estimated $11K.
  • Convergence Investment Partners first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2017 and held it in 2 quarters.
  • Convergence Investment Partners's DIPLOMAT PHARMACY, INC. position peaked at $1.78M in Q4 2017.
  • 206 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2018.

Based on Convergence Investment Partners's 13F filing for Q2 2018, filed 7 Aug 2018.